SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Ascendis Pharma Q1 EPS Euro (1.320) Beats Euro (1.500) Estimate

Ascendis Pharma (NASDAQ:ASND) reported quarterly losses of $(1.320) per share which beat the analyst consensus estimate of $(1.500) by 12 percent. This is a 4.35 percent increase over losses of $(1.380) per share from

Benzinga · 05/19/2020 20:03

Ascendis Pharma (NASDAQ:ASND) reported quarterly losses of $(1.320) per share which beat the analyst consensus estimate of $(1.500) by 12 percent. This is a 4.35 percent increase over losses of $(1.380) per share from the same period last year.